Organic-Inorganic Hybrid Hollow Mesoporous Organosilica Nanoparticles for Efficient Ultrasound-Based Imaging and Controlled Drug Release
Figure 4
In vivo ultrasound imaging of tumor-bearing mice before ((a), (c), and (e)) and after ((b), (d), and (f)) the administration of different contrast agents: saline solution (a and b), PTX-HPMOs (c and d), and SonoVue (e and f). Images (g) and (h) represent tumor ultrasound images after 7 days of administration of PTX-HPMOs (g) and SonoVue (h).
